MICHAEL MOZIAK: Open Payments
NPI 1336592872 · HENDERSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,473 in 47 payments from 7 companies in 2025. Trend: 2023 $879 · 2024 $810 · 2025 $1,473
Food & beverage: $1,473
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 16 | $733 |
| Abbott Laboratories | 4 | $251 |
| Collegium Pharmaceutical, Inc. | 13 | $207 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $146 |
| SCILEX PHARMACEUTICALS INC. | 4 | $70 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $48 |
| Virtus Pharmaceuticals LLC | 1 | $18 |
Products named: PROLATE, Belbuca, ETERNA, RELISTOR, PROCLAIM, ZTLido, JOURNAVX, LEVORPHANOL TARTRATE.
Industry payments across NC — which companies pay providers there.
